The proteasomal subunit S6 ATPase is a novel synphilin‐1 interacting protein—implications for Parkinson's disease

Frank P. Marx(Hertie Institute for Clinical Brain Research), Anne S. Soehn(University of Tübingen), Daniela Berg(Hertie Institute for Clinical Brain Research), Christian Melle(Friedrich Schiller University Jena), Carola Schiesling(Hertie Institute for Clinical Brain Research), Mira Lang(Hertie Institute for Clinical Brain Research), Sabine Kautzmann(Hertie Institute for Clinical Brain Research), Karsten M. Strauss(Hertie Institute for Clinical Brain Research), Thomas Franck(University of Tübingen), Simone Engelender(Technion – Israel Institute of Technology), Jens Pahnke(University Hospital of Zurich), Simon Dawson(University of Nottingham), Ferdinand von Eggeling(Friedrich Schiller University Jena), Jörg B. Schulz(Hertie Institute for Clinical Brain Research), Olaf Rieß(University of Tübingen), Rejko Krüger(Hertie Institute for Clinical Brain Research)
The FASEB Journal
February 27, 2007
Cited by 54

Abstract

ABSTRACT Synphilin‐1 is linked to Parkinson's disease (PD), based on its role as an alpha‐synuclein (PARK1)‐interacting protein and substrate of the ubiquitin E3 ligase Parkin (PARK2) and because of its presence in Lewy bodies (LB) in brains of PD patients. We found that overexpression of synphilin‐1 in cells leads to the formation of ubiquitinated cytoplasmic inclusions supporting a derangement of the ubiquitin‐proteasome system in PD. We report here a novel specific interaction of synphilin‐1 with the regulatory proteasomal protein S6 ATPase (tbp7). Functional characterization of this interaction on a cellular level revealed colocalization of S6 and synphilin‐1 in aggresome‐like intracytoplasmic inclusions. Overexpression of synphilin‐1 and S6 in cells caused reduced proteasomal activity associated with a significant increase in inclusion formation compared to cells expressing syn‐philin‐1 alone. Steady‐state levels of synphilin‐1 in cells were not altered after cotransfection of S6 and colocal‐ization of synphilin‐1‐positive inclusions with lysosomal markers suggests the presence of an alternative lysosomal degradation pathway. Subsequent immunohistochemical studies in brains of PD patients identified S6 ATPase as a component of LB. This is the first study investigating the physiological role of synphilin‐1 in the ubiquitin protea‐some system. Our data suggest a direct interaction of synphilin‐1 with the regulatory complex of the protea‐some modulating proteasomal function.—Marx F. P., Soehn, A. S., Berg, D., Melle, C., Schiesling, C., Lang, M., Kautzmann, S., Strauss, K. M., Franck, T., Engelender, S., Pahnke, J., Dawson, S., von Eggeling F., Schulz, J. B., Riess, O., Krüger R. The proteasomal subunit S6 ATPase is a novel synphilin‐1 interacting protein—implications for Parkinson's disease. FASEB J. 21, 1759–1767 (2007)


Related Papers

No related papers found

Powered by citation graph analysis